Can vibration supercharge brain training for movement?
NCT ID NCT06845176
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study explores how combining mental movement practice (motor imagery) with tendon vibration affects brain activity. Thirty-three healthy adults will try three different timing combinations of vibration and imagery. Researchers will measure brain responses using magnetic stimulation and EEG to see which method works best. The goal is to improve future rehabilitation for people who have trouble moving.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Tendon vibration device and kinesthetic motor imagery
- What this could lead to
- If successful, this could help design better rehabilitation techniques for people with limited mobility, such as stroke survivors or those with paralysis.
- What could go wrong
- This is a small, early-stage study in healthy volunteers, so results may not directly apply to patients. The approach may not improve motor imagery effectiveness as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRMIS-Hôpital Nord
RECRUITINGSaint-Etienne, France, 42055, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the Brain's visual priorities?
- A new eye on the brain: could this tracer unlock Addiction's secrets?
- First look: can a new drug candidate pass early safety tests in humans?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- Can a Two-Pathway pill improve ED treatment? a new trial puts the combo to the test
- Could a common drug shield the brain from Alzheimer's?